| Term 
 
        | Oxytocin (Pitocin®, Syntocinon®) |  | Definition 
 
        | Use: Uterine stimulation, induce labor at term; prevention of hemorrhage; stimulation of milke let down reflex PHK: IC, IM, nasal rout Adverse: water intoxication, uterine rupture, anaphylaxis, sinus brady |  | 
        |  | 
        
        | Term 
 
        | Dinoprostone (Prostin E2®) |  | Definition 
 
        | Prostaglandin Use: Uterine stimulation, expulsion of uterine contents in instances of intrauterine fetal death, missed abortion, elective abortion Adverse: GI distrubances, vomiting, diarrhea Other drugs: Carboprost Tromethamine (Prostin/M15®, Hemabate®) |  | 
        |  | 
        
        | Term 
 
        | Ergonovine Maleate (Ergotrate®) |  | Definition 
 
        | Ergot Alkaloids Use: Uterine stimulation, decrease uterine bleeding AFTER completion of labor and delivery Mechanism: contraction of uterine smooth muscle through activation of serotonin and a-adrenergic receptors Contraindications: don't use to induce labor (fetal hypoxia), hepatic or renal diseas Other drugs: Methylergonovine Maleate (Methergine) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Use: Uterine Relaxation (tocolytic), prevent premature labor; may be given to pre-eclamptic pts to prevent convulsions or as tx for exlamptic pts Not FDA approved; 1st line though |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Use: Uterine relaxation (tocolytic agent), prevent premature labor Mechanism: Ca channel blocker Not FDA approved; Starting to be 1st line though |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Use: Uterine relaxation (tocolytic agent), prevent premature labor Mechanism: Reduction of prostaglandin synthesis (prostaglandins = uterine contraction) Adverse: partial closure of fetal ductus arteriosus Not FDA approved |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Use: Uterine relaxation (tocolytic agent), prevent premature labor; prophylactic (16th to 37th week of pregnancy); NOT EFFECTIVE ACUTELY NOT FDA approved |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Use: Uterine relaxation (tocolytic agents), prevent premature labor; EMERGENCY USE ONLY! |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Use: Uterine relaxant (tocolytic agent), prevent premature labor Mechanism: Direct relaxant effect on myometrium and inhibition of oxytocin release Not FDA approved |  | 
        |  |